CLINICAL_TRIALS
trial_result
· 2014-12-30
Clinical Trial Update: A Companion Study for Studies THAL-MM-003, CC-5013-MM-009, and CC-5013-MM-010 for Subjects With Multiple Myeloma [Phase 3]
Summary
Phase 3 companion study update for multiple myeloma trials, with completed status and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Celgene | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2014-12-30